Hodgkin Lymphoma Survivors Face Quality of Life Deficits Decades After Diagnosis

Significant progress in therapeutic protocols and early detection has led to a continuous decline in cancer mortality, with over 4 million deaths averted in the United States since 1991 [1, 2, 3]. This success has created a rapidly expanding population of survivors, which is projected to reach 22.1 million by 2030 [4]. While acute treatment toxicities are well-documented, the medical community is increasingly focused on the long-term psychosocial and physical needs of patients who live decades past their diagnosis [5]. In Hodgkin lymphoma specifically, high clinical cure rates necessitate a deeper understanding of whether survivors regain a quality of life comparable to their healthy peers, particularly as research indicates progressive declines in cardiorespiratory fitness (the capacity of the cardiovascular and respiratory systems to supply oxygen during sustained physical activity) and increased fatigue in this population [6]. A new nationwide analysis provides critical data on the persistence of symptomatic burdens among these long-term survivors.